13F filer · CIK 1381843
Atle Fund Management AB
STOCKHOLM, V7 · filing since Q4 2013 · last filing Jul 24, 2026
Reported value
$371.7M
+$62.0M vs prior
Positions
39
New / sold out
3 / 3
Added / reduced
16 / 20
Turnover
29.0%
buys $98.7M · sells $289.2M
Top-10 weight
48.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | MERCK & CO. INC | +155,504 | +459.4% | +$20.0M |
| New | BIOGEN INC | +62,781 | – | +$13.6M |
| Added | CVSCVS HEALTH CORP | +122,329 | +514.6% | +$12.7M |
| Added | IONIS PHARMACEUTICALS INC | +109,258 | +392.0% | +$8.7M |
| Added | TANGO THERAPEUTICS INC | +168,642 | +563.7% | +$5.3M |
| New | ORUKA THERAPEUTI | +54,886 | – | +$5.2M |
| Added | NEWAMSTERDAM PHARMA CO NV | +154,052 | +162.5% | +$5.2M |
| Added | BOSTON SCIENTIFC | +105,949 | +262.0% | +$4.5M |
| Added | IRHYTHM TECHNOLOGIES INC | +31,780 | +142.4% | +$3.8M |
| Added | ABIVAX SA | +26,580 | +84.1% | +$3.5M |
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | REVOLUTION MEDICINES INC | -544,168 | -88.2% | $-101.9M |
| Reduced | DEXCOM INC | -512,486 | -87.7% | $-34.5M |
| Reduced | BICARA THERAPEUTICS INC | -1,023,977 | -87.5% | $-30.4M |
| Reduced | CARDINAL HEALTH INC | -85,052 | -78.3% | $-20.2M |
| Reduced | INTUITIVE SURGICAL INC | -46,195 | -65.2% | $-18.4M |
| Reduced | LLYELI LILLY & CO | -9,901 | -24.9% | $-11.9M |
| Reduced | CELCUITY INC | -107,983 | -76.4% | $-11.3M |
| Reduced | MIRUM PHARMACEUTICALS INC | -94,961 | -48.5% | $-11.1M |
| Reduced | ABBVIE INC | -43,856 | -40.5% | $-11.0M |
| Sold out | AMGEN INC | -21,903 | -100.0% | $-8.7M |
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | LLYELI LILLY & CO | 29,821 | $35.8M | 9.62% |
| 2 | MERCK & CO. INCCOM | 189,357 | $24.3M | 6.55% |
| 3 | JNJJOHNSON & JOHNSON | 85,425 | $21.7M | 5.84% |
| 4 | ABBVIE INCCOM | 64,325 | $16.2M | 4.35% |
| 5 | CVSCVS HEALTH CORP | 146,102 | $15.1M | 4.07% |
| 6 | THERMO FISHER SCIENTIFIC CORPCOM | 27,859 | $14.0M | 3.76% |
| 7 | REVOLUTION MEDICINES INCCOM | 73,077 | $13.7M | 3.68% |
| 8 | BIOGEN INCCOM | 62,781 | $13.6M | 3.65% |
| 9 | NEUROCRINE BIOSCIENCES INCCOM | 72,898 | $12.3M | 3.31% |
| 10 | MIRUM PHARMACEUTICALS INCCOM | 100,807 | $11.8M | 3.17% |
29 more rows. Subscribe for $29/month to see every row, download the data and use the API.